Logo

American Heart Association

  107
  0


Final ID:

SMART (primary results at ACC)

  • Mehran, Roxana  ( ICAHN SCHOOL OF MEDICINE MT SINAI , New York , New York , United States )
  • Herrmann, Howard  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    ROXANA MEHRAN: DO have relevant financial relationships ; Consultant:Abbott, Affluent Medical, Alleviant Medical, Amgen, AstraZeneca, BAIM, Beth Israel Deaconess Medical Center, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CERC, Chiesi, Concept Medical, Daiichi Sankyo, Duke, Faraday, Idorsia, Janssen, MedAlliance, Medscape, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Pi-Cardia, Protembis, RM Global Bioaccess Fund Management, Sanofi:Active (exists now) ; Advisor:AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program):Active (exists now) ; Other (please indicate in the box next to the company name):SCAI (Women in Innovations Committee Member), Faculty CRF, Women as One:Active (exists now) ; Individual Stocks/Stock Options:Elixir Medical, Stel, ControlRad (spouse):Active (exists now) ; Speaker:Affluent Medical, Boehringer Ingelheim, Chiesi USA, Cordis, Esperion Science/Innovative Biopharma, Gaffney Events, Educational Trust, Global Clinical Trial Partners, Ltd., IQVIA, Medscape/WebMD Global, NovoNordisk, PeerView Institute for Medical Education, TERUMO Europe N.V., Radcliffe:Active (exists now) | Howard Herrmann: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
TRISCEND II 1-Year Outcomes (primary results at TCT)

Hahn Rebecca, Thourani Vinod, Kodali Susheel

Panel Discussion

Hahn Rebecca

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available